http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PH-12018501235-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
filingDate 2018-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90a465d5dc57b6d2bc8126f6e3c58855
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f68656dc726dceefee5de09aff52b68e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df40f2514fb246707ebccceb00708d08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab780f7d87006a9a384e6a572d086525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eaf69a1965e4db0b106783cb39e2963
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06d1e1312b5fc7d66b94f3cb224743a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_475ab0ed9ecf88556aa7d12cfa34df10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43e77e8b5e043739379cc9eb7e7648b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91b87c22b0f1c05fb23ce7012c0af5cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bde20eaa2d101fee6e7de5866cb1ffc
publicationDate 2019-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PH-12018501235-A1
titleOfInvention 2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disorders
abstract The invention relates to 2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine derivatives as selective blockers of TASK-1 and TASK-3 channels, for the treatment and/or prevention of breathing disorders including sleep-related breathing disorders such as obstructive and central sleep apnea and snoring.
priorityDate 2015-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2760400
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID51305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416173868
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID84429
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID223604
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID494803

Total number of triples: 33.